These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 27206279

  • 1. High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
    Mortensen KM, Itenov TS, Haase N, Müller RB, Ostrowski SR, Johansson PI, Olsen NV, Perner A, Søe-Jensen P, Bestle MH.
    Shock; 2016 Oct; 46(4):365-72. PubMed ID: 27206279
    [Abstract] [Full Text] [Related]

  • 2. Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.
    Iapichino G, Umbrello M, Albicini M, Spanu P, Bellani G, Polli F, Pavlovic R, Cugno M, Fermo I, Paroni R.
    Minerva Anestesiol; 2010 May; 76(5):325-33. PubMed ID: 20395894
    [Abstract] [Full Text] [Related]

  • 3. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.
    Winkler MS, Nierhaus A, Rösler G, Lezius S, Harlandt O, Schwedhelm E, Böger RH, Kluge S.
    Crit Care; 2018 Sep 19; 22(1):216. PubMed ID: 30231905
    [Abstract] [Full Text] [Related]

  • 4. Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.
    Aucella F, Maas R, Vigilante M, Tripepi G, Schwedhelm E, Margaglione M, Gesualdo L, Boeger R, Zoccali C.
    Atherosclerosis; 2009 Dec 19; 207(2):541-5. PubMed ID: 19501358
    [Abstract] [Full Text] [Related]

  • 5. Asymmetric dimethylarginine and L-arginine levels in neonatal sepsis and septic shock.
    Aydemir O, Ozcan B, Yucel H, Bas AY, Demirel N.
    J Matern Fetal Neonatal Med; 2015 May 19; 28(8):977-82. PubMed ID: 24983667
    [Abstract] [Full Text] [Related]

  • 6. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE, Zawada AM, Martens-Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.
    Clin Res Cardiol; 2018 Mar 19; 107(3):201-213. PubMed ID: 29101459
    [Abstract] [Full Text] [Related]

  • 7. Monitoring of L-Arginine and Endogenous Dimethylarginines in Survivor Septic Patients - A Pilot Study.
    Németh B, Kiss I, Péter I, Ajtay Z, Németh Á, Márk L, Csorba A, Kőszegi T, Mühl D, Kustán P.
    In Vivo; 2018 Mar 19; 30(5):663-9. PubMed ID: 27566088
    [Abstract] [Full Text] [Related]

  • 8. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.
    Lung; 2017 Dec 19; 195(6):717-727. PubMed ID: 28852826
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity.
    Lambden S, Tomlinson J, Piper S, Gordon AC, Leiper J.
    Crit Care; 2018 Dec 11; 22(1):336. PubMed ID: 30538005
    [Abstract] [Full Text] [Related]

  • 10. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
    Vögeli A, Ottiger M, Meier MA, Steuer C, Bernasconi L, Kulkarni P, Huber A, Christ-Crain M, Henzen C, Hoess C, Thomann R, Zimmerli W, Mueller B, Schuetz P.
    Respir Res; 2017 Jan 23; 18(1):25. PubMed ID: 28114935
    [Abstract] [Full Text] [Related]

  • 11. Associations of Plasma Nitrite, L-Arginine and Asymmetric Dimethylarginine With Morbidity and Mortality in Patients With Necrotizing Soft Tissue Infections.
    Hansen MB, Rasmussen LS, Garred P, Pilely K, Wahl AM, Perner A, Madsen MB, Hedegaard ER, Simonsen U, Hyldegaard O.
    Shock; 2018 Jun 23; 49(6):667-674. PubMed ID: 28863028
    [Abstract] [Full Text] [Related]

  • 12. Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
    Meinitzer A, Kielstein JT, Pilz S, Drechsler C, Ritz E, Boehm BO, Winkelmann BR, März W.
    Clin Chem; 2011 Jan 23; 57(1):112-21. PubMed ID: 21036946
    [Abstract] [Full Text] [Related]

  • 13. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.
    Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamada S, Shoji H, Takeuchi M, Ueda S, Matsui T, Adachi H, Okuda S, Yamagishi S.
    Pharmacol Res; 2009 Dec 23; 60(6):515-8. PubMed ID: 19450686
    [Abstract] [Full Text] [Related]

  • 14. Increased levels of symmetric dimethyl-arginine are associated with all-cause mortality in patients with symptomatic peripheral arterial disease.
    Staniszewska A, Rajagopalan S, Al-Shaheen A, Thies F, Brittenden J.
    J Vasc Surg; 2015 May 23; 61(5):1292-8. PubMed ID: 25776186
    [Abstract] [Full Text] [Related]

  • 15. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
    Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Böger RH.
    Atherosclerosis; 2010 Feb 23; 208(2):518-23. PubMed ID: 19700158
    [Abstract] [Full Text] [Related]

  • 16. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.
    Shafi T, Hostetter TH, Meyer TW, Hwang S, Hai X, Melamed ML, Banerjee T, Coresh J, Powe NR.
    Am J Kidney Dis; 2017 Jul 23; 70(1):48-58. PubMed ID: 28089476
    [Abstract] [Full Text] [Related]

  • 17. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G.
    Kidney Int Suppl; 2001 Feb 23; 78():S14-8. PubMed ID: 11168976
    [Abstract] [Full Text] [Related]

  • 18. Association of homoarginine and methylarginines with liver dysfunction and mortality in chronic liver disease.
    Pilz S, Putz-Bankuti C, Meinitzer A, März W, Kienreich K, Stojakovic T, Pieber TR, Stauber RE.
    Amino Acids; 2015 Sep 23; 47(9):1817-26. PubMed ID: 25952253
    [Abstract] [Full Text] [Related]

  • 19. Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension.
    Gamil S, Erdmann J, Schwedhelm E, Bakheit KH, Abdalrahman IBB, Mohamed AO.
    Kidney Blood Press Res; 2020 Sep 23; 45(5):727-736. PubMed ID: 32814314
    [Abstract] [Full Text] [Related]

  • 20. Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis.
    Davis JS, Darcy CJ, Yeo TW, Jones C, McNeil YR, Stephens DP, Celermajer DS, Anstey NM.
    PLoS One; 2011 Feb 18; 6(2):e17260. PubMed ID: 21364995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.